2RSY

Solution structure of the SH2 domain of Csk in complex with a phosphopeptide from Cbp

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-1, 20 mM sodium phosphate-2, 50 mM sodium chloride-3, 0.5-1.0 mM Cbp phosphopeptide-4, 90 % H2O-5, 10 % [U-99% 2H] D2O-6	90% H2O/10% D2O	0.076	6.0	ambient	298
2	2D 1H-15N HSQC	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-13, 20 mM sodium phosphate-14, 50 mM sodium chloride-15, 0.5-1.0 mM Csk SH2 domain-16, 90 % H2O-17, 10 % [U-99% 2H] D2O-18	90% H2O/10% D2O	0.076	6.0	ambient	298
3	3D HNCACB	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-1, 20 mM sodium phosphate-2, 50 mM sodium chloride-3, 0.5-1.0 mM Cbp phosphopeptide-4, 90 % H2O-5, 10 % [U-99% 2H] D2O-6	90% H2O/10% D2O	0.076	6.0	ambient	298
4	3D HNCACB	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-13, 20 mM sodium phosphate-14, 50 mM sodium chloride-15, 0.5-1.0 mM Csk SH2 domain-16, 90 % H2O-17, 10 % [U-99% 2H] D2O-18	90% H2O/10% D2O	0.076	6.0	ambient	298
5	3D CBCA(CO)NH	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-1, 20 mM sodium phosphate-2, 50 mM sodium chloride-3, 0.5-1.0 mM Cbp phosphopeptide-4, 90 % H2O-5, 10 % [U-99% 2H] D2O-6	90% H2O/10% D2O	0.076	6.0	ambient	298
6	3D CBCA(CO)NH	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-13, 20 mM sodium phosphate-14, 50 mM sodium chloride-15, 0.5-1.0 mM Csk SH2 domain-16, 90 % H2O-17, 10 % [U-99% 2H] D2O-18	90% H2O/10% D2O	0.076	6.0	ambient	298
7	3D HNCO	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-1, 20 mM sodium phosphate-2, 50 mM sodium chloride-3, 0.5-1.0 mM Cbp phosphopeptide-4, 90 % H2O-5, 10 % [U-99% 2H] D2O-6	90% H2O/10% D2O	0.076	6.0	ambient	298
8	3D HNCO	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-13, 20 mM sodium phosphate-14, 50 mM sodium chloride-15, 0.5-1.0 mM Csk SH2 domain-16, 90 % H2O-17, 10 % [U-99% 2H] D2O-18	90% H2O/10% D2O	0.076	6.0	ambient	298
9	3D HN(CA)CO	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-1, 20 mM sodium phosphate-2, 50 mM sodium chloride-3, 0.5-1.0 mM Cbp phosphopeptide-4, 90 % H2O-5, 10 % [U-99% 2H] D2O-6	90% H2O/10% D2O	0.076	6.0	ambient	298
10	3D HN(CA)CO	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-13, 20 mM sodium phosphate-14, 50 mM sodium chloride-15, 0.5-1.0 mM Csk SH2 domain-16, 90 % H2O-17, 10 % [U-99% 2H] D2O-18	90% H2O/10% D2O	0.076	6.0	ambient	298
11	3D HBHA(CO)NH	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-1, 20 mM sodium phosphate-2, 50 mM sodium chloride-3, 0.5-1.0 mM Cbp phosphopeptide-4, 90 % H2O-5, 10 % [U-99% 2H] D2O-6	90% H2O/10% D2O	0.076	6.0	ambient	298
12	3D HBHA(CO)NH	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-13, 20 mM sodium phosphate-14, 50 mM sodium chloride-15, 0.5-1.0 mM Csk SH2 domain-16, 90 % H2O-17, 10 % [U-99% 2H] D2O-18	90% H2O/10% D2O	0.076	6.0	ambient	298
13	3D 1H-15N TOCSY	0.5-1.0 mM [U-15N] Csk SH2 domain-7, 20 mM sodium phosphate-8, 50 mM sodium chloride-9, 0.5-1.0 mM Cbp phosphopeptide-10, 90 % H2O-11, 10 % [U-99% 2H] D2O-12	90% H2O/10% D2O	0.076	6.0	ambient	298
14	3D 1H-15N TOCSY	0.5-1.0 mM [U-15N] Cbp phosphopeptide-19, 20 mM sodium phosphate-20, 50 mM sodium chloride-21, 0.5-1.0 mM Csk SH2 domain-22, 90 % H2O-23, 10 % [U-99% 2H] D2O-24	90% H2O/10% D2O	0.076	6.0	ambient	298
15	2D 1H-13C HSQC	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-25, 20 mM sodium phosphate-26, 50 mM sodium chloride-27, 0.5-1.0 mM Cbp phosphopeptide-28, 90 % H2O-29, 10 % [U-99% 2H] D2O-30	100% D2O	0.076	6.0	ambient	298
16	2D 1H-13C HSQC	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-31, 20 mM sodium phosphate-32, 50 mM sodium chloride-33, 0.5-1.0 mM Csk SH2 domain-34, 90 % H2O-35, 10 % [U-2H] D2O-36	100% D2O	0.076	6.0	ambient	298
17	2D 1H-13C HSQC aromatic	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-25, 20 mM sodium phosphate-26, 50 mM sodium chloride-27, 0.5-1.0 mM Cbp phosphopeptide-28, 90 % H2O-29, 10 % [U-99% 2H] D2O-30	100% D2O	0.076	6.0	ambient	298
18	2D 1H-13C HSQC aromatic	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-31, 20 mM sodium phosphate-32, 50 mM sodium chloride-33, 0.5-1.0 mM Csk SH2 domain-34, 90 % H2O-35, 10 % [U-2H] D2O-36	100% D2O	0.076	6.0	ambient	298
19	3D 1H-13C NOESY aromatic	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-25, 20 mM sodium phosphate-26, 50 mM sodium chloride-27, 0.5-1.0 mM Cbp phosphopeptide-28, 90 % H2O-29, 10 % [U-99% 2H] D2O-30	100% D2O	0.076	6.0	ambient	298
20	3D 1H-13C NOESY aromatic	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-31, 20 mM sodium phosphate-32, 50 mM sodium chloride-33, 0.5-1.0 mM Csk SH2 domain-34, 90 % H2O-35, 10 % [U-2H] D2O-36	100% D2O	0.076	6.0	ambient	298
21	2D DQF-COSY	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-25, 20 mM sodium phosphate-26, 50 mM sodium chloride-27, 0.5-1.0 mM Cbp phosphopeptide-28, 90 % H2O-29, 10 % [U-99% 2H] D2O-30	100% D2O	0.076	6.0	ambient	298
22	3D C(CO)NH	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-1, 20 mM sodium phosphate-2, 50 mM sodium chloride-3, 0.5-1.0 mM Cbp phosphopeptide-4, 90 % H2O-5, 10 % [U-99% 2H] D2O-6	90% H2O/10% D2O	0.076	6.0	ambient	298
23	3D C(CO)NH	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-13, 20 mM sodium phosphate-14, 50 mM sodium chloride-15, 0.5-1.0 mM Csk SH2 domain-16, 90 % H2O-17, 10 % [U-99% 2H] D2O-18	90% H2O/10% D2O	0.076	6.0	ambient	298
24	3D H(CCO)NH	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-1, 20 mM sodium phosphate-2, 50 mM sodium chloride-3, 0.5-1.0 mM Cbp phosphopeptide-4, 90 % H2O-5, 10 % [U-99% 2H] D2O-6	90% H2O/10% D2O	0.076	6.0	ambient	298
25	3D H(CCO)NH	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-13, 20 mM sodium phosphate-14, 50 mM sodium chloride-15, 0.5-1.0 mM Csk SH2 domain-16, 90 % H2O-17, 10 % [U-99% 2H] D2O-18	90% H2O/10% D2O	0.076	6.0	ambient	298
26	3D HCCH-TOCSY	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-25, 20 mM sodium phosphate-26, 50 mM sodium chloride-27, 0.5-1.0 mM Cbp phosphopeptide-28, 90 % H2O-29, 10 % [U-99% 2H] D2O-30	100% D2O	0.076	6.0	ambient	298
27	3D HCCH-TOCSY	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-31, 20 mM sodium phosphate-32, 50 mM sodium chloride-33, 0.5-1.0 mM Csk SH2 domain-34, 90 % H2O-35, 10 % [U-2H] D2O-36	100% D2O	0.076	6.0	ambient	298
28	3D 1H-15N NOESY	0.5-1.0 mM [U-15N] Csk SH2 domain-7, 20 mM sodium phosphate-8, 50 mM sodium chloride-9, 0.5-1.0 mM Cbp phosphopeptide-10, 90 % H2O-11, 10 % [U-99% 2H] D2O-12	90% H2O/10% D2O	0.076	6.0	ambient	298
29	3D 1H-15N NOESY	0.5-1.0 mM [U-15N] Cbp phosphopeptide-19, 20 mM sodium phosphate-20, 50 mM sodium chloride-21, 0.5-1.0 mM Csk SH2 domain-22, 90 % H2O-23, 10 % [U-99% 2H] D2O-24	90% H2O/10% D2O	0.076	6.0	ambient	298
30	3D 1H-13C NOESY	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-25, 20 mM sodium phosphate-26, 50 mM sodium chloride-27, 0.5-1.0 mM Cbp phosphopeptide-28, 90 % H2O-29, 10 % [U-99% 2H] D2O-30	100% D2O	0.076	6.0	ambient	298
31	3D 1H-13C NOESY	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-31, 20 mM sodium phosphate-32, 50 mM sodium chloride-33, 0.5-1.0 mM Csk SH2 domain-34, 90 % H2O-35, 10 % [U-2H] D2O-36	100% D2O	0.076	6.0	ambient	298
32	2D CBHD	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-25, 20 mM sodium phosphate-26, 50 mM sodium chloride-27, 0.5-1.0 mM Cbp phosphopeptide-28, 90 % H2O-29, 10 % [U-99% 2H] D2O-30	100% D2O	0.076	6.0	ambient	298
33	2D CBHD	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-31, 20 mM sodium phosphate-32, 50 mM sodium chloride-33, 0.5-1.0 mM Csk SH2 domain-34, 90 % H2O-35, 10 % [U-2H] D2O-36	100% D2O	0.076	6.0	ambient	298
34	2D CBHE	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-25, 20 mM sodium phosphate-26, 50 mM sodium chloride-27, 0.5-1.0 mM Cbp phosphopeptide-28, 90 % H2O-29, 10 % [U-99% 2H] D2O-30	100% D2O	0.076	6.0	ambient	298
35	2D CBHE	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-31, 20 mM sodium phosphate-32, 50 mM sodium chloride-33, 0.5-1.0 mM Csk SH2 domain-34, 90 % H2O-35, 10 % [U-2H] D2O-36	100% D2O	0.076	6.0	ambient	298
36	3D 13C-filtered/13C-edited NOESY	0.5-1.0 mM [U-13C; U-15N] Csk SH2 domain-25, 20 mM sodium phosphate-26, 50 mM sodium chloride-27, 0.5-1.0 mM Cbp phosphopeptide-28, 90 % H2O-29, 10 % [U-99% 2H] D2O-30	100% D2O	0.076	6.0	ambient	298
37	3D 13C-filtered/13C-edited NOESY	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-31, 20 mM sodium phosphate-32, 50 mM sodium chloride-33, 0.5-1.0 mM Csk SH2 domain-34, 90 % H2O-35, 10 % [U-2H] D2O-36	100% D2O	0.076	6.0	ambient	298
38	3D 13C,15N-filtered/15N-edited NOESY	0.5-1.0 mM [U-13C; U-15N] Cbp phosphopeptide-13, 20 mM sodium phosphate-14, 50 mM sodium chloride-15, 0.5-1.0 mM Csk SH2 domain-16, 90 % H2O-17, 10 % [U-99% 2H] D2O-18	90% H2O/10% D2O	0.076	6.0	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800
2	Bruker	DRX	800

NMR Refinement
Method	Details	Software
simulated annealing, torsion angle dynamics		XwinNMR

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	XwinNMR		Bruker Biospin
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	peak picking	Sparky		Goddard
4	chemical shift assignment	Sparky		Goddard
5	data analysis	Sparky		Goddard
6	data analysis	TALOS		Cornilescu, Delaglio and Bax
7	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
8	geometry optimization	MOLMOL		Koradi, Billeter and Wuthrich
9	refinement	CYANA